Recursion Pharmaceuticals (RXRX) FCF Margin (QoQ) (2020 - 2026)
Recursion Pharmaceuticals (RXRX) FCF Margin (QoQ) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Recursion Pharmaceuticals | 1.59 Bn | 933.22 Mn | -6.02 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -114,215.00 |
| Dec 31, 2025 | 224,877.00 |
| Sep 30, 2025 | -197,434.00 |
| Jun 30, 2025 | 51,798.00 |
| Mar 31, 2025 | 166,036.00 |
| Dec 31, 2024 | -229,521.00 |
| Sep 30, 2024 | 25,545.00 |
| Jun 30, 2024 | 26,190.00 |
| Mar 31, 2024 | 8.00 |
| Dec 31, 2023 | -9,769.00 |
| Sep 30, 2023 | -12,677.00 |
| Jun 30, 2023 | 8,140.00 |
| Mar 31, 2023 | -33,796.00 |
| Dec 31, 2022 | 9,732.00 |
| Sep 30, 2022 | 39,459.00 |
| Jun 30, 2022 | -217,052.00 |
| Mar 31, 2022 | 396,038.00 |
| Dec 31, 2021 | -90,347.00 |
| Sep 30, 2021 | 61,079.00 |
| Jun 30, 2021 | -107,005.00 |